Neutron-activatable needles for radionuclide therapy of solid tumors.

about

Neutron-activatable needles for radionuclide therapy of solid tumors.

Item

http://www.wikidata.org/entity/Q44874712

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Neutron-activatable needles for radionuclide therapy of solid tumors.

@en

Neutron-activatable needles for radionuclide therapy of solid tumors.

@nl

type

Item

label

Neutron-activatable needles for radionuclide therapy of solid tumors.

@en

Neutron-activatable needles for radionuclide therapy of solid tumors.

@nl

altLabel

Neutron-activatable needles for radionuclide therapy of solid tumors

@en

prefLabel

Neutron-activatable needles for radionuclide therapy of solid tumors.

@en

Neutron-activatable needles for radionuclide therapy of solid tumors.

@nl

P1476

Neutron-activatable needles for radionuclide therapy of solid tumors

@en

P2093

Michael Jay

http://www.w3.org/2001/XMLSchema#string

Roger J Narayan

http://www.w3.org/2001/XMLSchema#string

Xiuling Lu

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2016

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world

Focused ultrasound-mediated drug delivery to pancreatic cancer in a mouse model.

Iontophoretic device delivery for the localized treatment of pancreatic ductal adenocarcinoma

Synthesis of Novel Thin-Film Materials by Pulsed Laser Deposition

Radionuclides delivery systems for nuclear imaging and radiotherapy of cancer.

Radioimmunotherapy of lymphoma: Bexxar and Zevalin.

Yttrium-90 (90Y) in the principal radionuclide therapies: an efficacy correlation between peptide receptor radionuclide therapy, radioimmunotherapy and transarterial radioembolization therapy. Ten years of experience (1999-2009).

Neutron-activatable holmium-containing mesoporous silica nanoparticles as a potential radionuclide therapeutic agent for ovarian cancer.

Radiation therapy for choroidal melanoma.

P304

3273-3280

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JBM.A.36185

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P50

Junghyun Kim

P577

2017-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28804994

http://www.w3.org/2001/XMLSchema#string

P921

biomedical engineering

P932

5753600

http://www.w3.org/2001/XMLSchema#string